Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan.
Aerts HJ, van Baardwijk AA, Petit SF, Offermann C, Loon Jv, Houben R, Dingemans AM, Wanders R, Boersma L, Borger J, Bootsma G, Geraedts W, Pitz C, Simons J, Wouters BG, Oellers M, Lambin P, Bosmans G, Dekker AL, De Ruysscher D. Aerts HJ, et al. Among authors: dingemans am. Radiother Oncol. 2009 Jun;91(3):386-92. doi: 10.1016/j.radonc.2009.03.006. Epub 2009 Mar 28. Radiother Oncol. 2009. PMID: 19329207 Free PMC article.
Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer.
De Ruysscher D, Dehing C, Yu S, Wanders R, Ollers M, Dingemans AM, Bootsma G, Hochstenbag M, Geraedts W, Pitz C, Simons J, Boersma L, Borger J, Dekker A, Lambin P. De Ruysscher D, et al. Among authors: dingemans am. Radiother Oncol. 2009 Jun;91(3):353-9. doi: 10.1016/j.radonc.2008.10.006. Epub 2008 Nov 13. Radiother Oncol. 2009. PMID: 19012981
Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): a prospective pilot study.
De Ruysscher D, Houben A, Aerts HJ, Dehing C, Wanders R, Ollers M, Dingemans AM, Hochstenbag M, Boersma L, Borger J, Dekker A, Lambin P. De Ruysscher D, et al. Among authors: dingemans am. Radiother Oncol. 2009 Jun;91(3):415-20. doi: 10.1016/j.radonc.2009.01.004. Epub 2009 Feb 3. Radiother Oncol. 2009. PMID: 19195730
Can we optimize chemo-radiation and surgery in locally advanced stage III non-small cell lung cancer based on evidence from randomized clinical trials? A hypothesis-generating study.
De Ruysscher D, Dehing C, Bentzen SM, Houben R, Dekker A, Wanders R, Borger J, Hochstenbag M, Boersma L, Geskes G, Dingemans AM, Bootsma G, Lammering G, Lambin P. De Ruysscher D, et al. Among authors: dingemans am. Radiother Oncol. 2009 Dec;93(3):389-95. doi: 10.1016/j.radonc.2009.06.004. Epub 2009 Jul 1. Radiother Oncol. 2009. PMID: 19576645 Review.
Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.
van Loon J, De Ruysscher D, Wanders R, Boersma L, Simons J, Oellers M, Dingemans AM, Hochstenbag M, Bootsma G, Geraedts W, Pitz C, Teule J, Rhami A, Thimister W, Snoep G, Dehing-Oberije C, Lambin P. van Loon J, et al. Among authors: dingemans am. Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):329-36. doi: 10.1016/j.ijrobp.2009.04.075. Epub 2009 Sep 24. Int J Radiat Oncol Biol Phys. 2010. PMID: 19782478
18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation.
van Loon J, Grutters JP, Wanders R, Boersma L, Dingemans AM, Bootsma G, Geraedts W, Pitz C, Simons J, Brans B, Snoep G, Hochstenbag M, Lambin P, De Ruysscher D. van Loon J, et al. Among authors: dingemans am. Eur J Cancer. 2010 Jan;46(1):110-9. doi: 10.1016/j.ejca.2009.10.028. Eur J Cancer. 2010. PMID: 19944595
Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer.
van Baardwijk A, Wanders S, Boersma L, Borger J, Ollers M, Dingemans AM, Bootsma G, Geraedts W, Pitz C, Lunde R, Lambin P, De Ruysscher D. van Baardwijk A, et al. Among authors: dingemans am. J Clin Oncol. 2010 Mar 10;28(8):1380-6. doi: 10.1200/JCO.2009.24.7221. Epub 2010 Feb 8. J Clin Oncol. 2010. PMID: 20142596
[¹⁸F]fluorodeoxyglucose uptake patterns in lung before radiotherapy identify areas more susceptible to radiation-induced lung toxicity in non-small-cell lung cancer patients.
Petit SF, van Elmpt WJ, Oberije CJ, Vegt E, Dingemans AM, Lambin P, Dekker AL, De Ruysscher D. Petit SF, et al. Among authors: dingemans am. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):698-705. doi: 10.1016/j.ijrobp.2010.06.016. Epub 2010 Sep 29. Int J Radiat Oncol Biol Phys. 2011. PMID: 20884128
Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study.
van Loon J, Offermann C, Ollers M, van Elmpt W, Vegt E, Rahmy A, Dingemans AM, Lambin P, De Ruysscher D. van Loon J, et al. Among authors: dingemans am. Radiother Oncol. 2011 May;99(2):172-5. doi: 10.1016/j.radonc.2011.03.014. Epub 2011 May 14. Radiother Oncol. 2011. PMID: 21571382 Free PMC article.
Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study.
Wanders R, Steevens J, Botterweck A, Dingemans AM, Reymen B, Baardwijk Av, Borger J, Bootsma G, Pitz C, Lunde R, Geraedts W, Lambin P, De Ruysscher D. Wanders R, et al. Among authors: dingemans am. Eur J Cancer. 2011 Dec;47(18):2691-7. doi: 10.1016/j.ejca.2011.06.023. Epub 2011 Jul 4. Eur J Cancer. 2011. PMID: 21733675 Free article.
325 results